P
BSX icon

&Partners’s Boston Scientific BSX Stock Holding History

&Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Sell
59,560
-9,706
-14% -$527K 0.01% 916
2026
Q1 		$4.3M Sell
69,266
-15,680
-18% -$1.25M 0.02% 574
2025
Q4 		$8.1M Buy
84,946
+9,354
+12% +$917K 0.04% 361
2025
Q3 		$7.37M Buy
75,592
+17,387
+30% +$1.8M 0.05% 330
2025
Q2 		$6.43M Buy
58,205
+2,189
+4% +$221K 0.05% 317
2025
Q1 		$5.55M Buy
56,016
+4,977
+10% +$501K 0.06% 278
2024
Q4 		$4.63M Buy
51,039
+14,771
+41% +$1.3M 0.06% 292
2024
Q3 		$3.04M Buy
36,268
+26,456
+270% +$2.09M 0.06% 284
2024
Q2 		$756K Buy
9,812
+4,796
+96% +$351K 0.03% 412
2024
Q1 		$344K Buy
+5,016
New +$323K 0.05% 338

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

&Partners's BSX Position: Q2 2026 in Review

&Partners reduced its Boston Scientific (BSX) stake by 14% in Q2 2026, selling an estimated $527K and leaving 59,560 shares worth $2.48M. The position accounts for 0.01% of the portfolio, ranked #916.

&Partners first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $8.1M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • &Partners held 59,560 shares of Boston Scientific worth $2.48M as of Q2 2026.
  • &Partners sold 9,706 Boston Scientific shares in Q2 2026, an estimated $527K.
  • Boston Scientific made up 0.01% of &Partners's portfolio in Q2 2026, its #916 holding.
  • &Partners first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • &Partners's Boston Scientific position peaked at $8.1M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.